Next Financial Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Next Financial Group’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-17	Closed	–	–	2477
2019 Q4	$0	Hold	17	–	–	﹤0.01%	2567
2019 Q3	$0	Hold	17	–	–	﹤0.01%	2464
2019 Q2	$0	Hold	17	–	–	﹤0.01%	2420
2019 Q1	$1K	Hold	17	–	–	﹤0.01%	1603
2018 Q4	$1K	Hold	17	–	–	﹤0.01%	1910
2018 Q3	$3K	Buy	+17	New	+$2.52K	﹤0.01%	1279
2017 Q4	–	Sell	-17	Closed	-$7K	–	1522
2017 Q3	$7K	Hold	17	–	–	﹤0.01%	1344
2017 Q2	$10K	Hold	17	–	–	﹤0.01%	1327
2017 Q1	$10K	Hold	17	–	–	﹤0.01%	1297
2016 Q4	$3K	Sell	17 -33	-66%	-$7.5K	﹤0.01%	2119
2016 Q3	$13K	Buy	+50	New	+$15.3K	﹤0.01%	1562

Other funds holding VYNT

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FPB

First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Next Financial Group's VYNT Position: Q1 2020 in Review

Next Financial Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2020, closing a stake of 17 shares.

Next Financial Group first reported a position in VYNT in Q3 2016 and held it in 11 quarters. The position peaked at $13K in Q3 2016. 13 funds tracked by Wall St. Rank hold VYNT as of Q1 2020.

Next Financial Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Next Financial Group sold 17 Vyant Bio, Inc. Common Stock shares in Q1 2020.
Next Financial Group first reported a position in Vyant Bio, Inc. Common Stock in Q3 2016 and held it in 11 quarters.
Next Financial Group's Vyant Bio, Inc. Common Stock position peaked at $13K in Q3 2016.
13 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2020.

Based on Next Financial Group's 13F filing for Q1 2020, filed 27 Apr 2020.